Editas Medicine, Inc.

EDITNASDAQHealthcare● Active

$2.67

$-0.05(-1.66%)

Market Cap$260904132

P/E Ratio—

52W High$4.537

52W Low$1.66

Avg Volume2.1M

Open$2.76

Beta2.10

Overview

Editas Medicine, Inc. (EDIT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · EDIT · as of Mar 9, 2026

Latest filing snapshot

-159-64.63%vs prior year

Editas Medicine, Inc. (EDIT) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-159

Growth % (1Y)

-64.63%

Revenue / Employee

$465.7K

Net Income / Employee

$-1.84M

Market Cap

$260M

EDIT Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-09	2025-12-31	87	-159	-64.63%
2025-03-05	2024-12-31	246	-19	-7.17%
2024-02-28	2023-12-31	265	+39	+17.26%
2023-02-22	2022-12-31	226	-38	-14.39%
2022-02-24	2021-12-31	264	+29	+12.34%
2021-02-26	2020-12-31	235	+27	+12.98%
2020-02-26	2019-12-31	208	+75	+56.39%
2019-03-01	2018-12-31	133	+21	+18.75%
2018-03-08	2017-12-31	112	+23	+25.84%
2017-03-03	2016-12-31	89	+22	+32.84%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ALLO

Allogene Therapeutics, Inc.

Capricor Therapeutics, Inc.

160$1.2B #4

KYTX

Kyverna Therapeutics, Inc.

112$330M #5

EDIT

Editas Medicine, Inc.YOU

87$260M #6

AVIR

Atea Pharmaceuticals, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · EDIT peer comparison

About EDIT employees

EDIT Employees · Headcount

Editas Medicine, Inc. (EDIT) employee data is sourced from the annual SEC 10-K filing. As of 2025, Editas Medicine, Inc. had 87 full-time employees globally. Full-time employees only. Global consolidated headcount.

Editas Medicine, Inc. employs 87 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $465,747, reflecting the company's operational efficiency.

Editas Medicine, Inc.'s workforce decreased by 159 (64.63%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Editas Medicine, Inc.'s revenue per employee of $465,747 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

EDIT Employees · 5 questions

As of the latest SEC 10-K filing (2025), Editas Medicine, Inc. had 87 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Editas Medicine, Inc. employee counthow many employees does Editas Medicine, Inc. haveEDIT total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09